Gilead Sciences Gross Profit 2006-2021 | GILD

Gilead Sciences annual/quarterly gross profit history and growth rate from 2006 to 2021. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Gilead Sciences gross profit for the quarter ending June 30, 2021 was $4.827B, a 18.34% increase year-over-year.
  • Gilead Sciences gross profit for the twelve months ending June 30, 2021 was $21.348B, a 22.53% increase year-over-year.
  • Gilead Sciences annual gross profit for 2020 was $20.117B, a 13.18% increase from 2019.
  • Gilead Sciences annual gross profit for 2019 was $17.774B, a 2.89% increase from 2018.
  • Gilead Sciences annual gross profit for 2018 was $17.274B, a 20.53% decline from 2017.
Gilead Sciences Annual Gross Profit
(Millions of US $)
2020 $20,117
2019 $17,774
2018 $17,274
2017 $21,736
2016 $26,129
2015 $28,633
2014 $21,102
2013 $8,343
2012 $7,231
2011 $6,261
2010 $6,080
2009 $5,416
2008 $4,209
2007 $3,461
2006 $2,593
2005 $1,768
Gilead Sciences Quarterly Gross Profit
(Millions of US $)
2021-06-30 $4,827
2021-03-31 $5,062
2020-12-31 $6,023
2020-09-30 $5,436
2020-06-30 $4,079
2020-03-31 $4,579
2019-12-31 $4,196
2019-09-30 $4,569
2019-06-30 $4,685
2019-03-31 $4,324
2018-12-31 $4,225
2018-09-30 $4,510
2018-06-30 $4,452
2018-03-31 $4,087
2017-12-31 $4,693
2017-09-30 $5,480
2017-06-30 $6,015
2017-03-31 $5,548
2016-12-31 $6,245
2016-09-30 $6,371
2016-06-30 $6,912
2016-03-31 $6,601
2015-12-31 $7,444
2015-09-30 $7,231
2015-06-30 $7,246
2015-03-31 $6,712
2014-12-31 $6,251
2014-09-30 $5,055
2014-06-30 $5,610
2014-03-31 $4,186
2013-12-31 $2,262
2013-09-30 $2,101
2013-06-30 $2,083
2013-03-31 $1,897
2012-12-31 $1,912
2012-09-30 $1,829
2012-06-30 $1,788
2012-03-31 $1,702
2011-12-31 $1,616
2011-09-30 $1,590
2011-06-30 $1,603
2011-03-31 $1,452
2010-12-31 $1,502
2010-09-30 $1,460
2010-06-30 $1,472
2010-03-31 $1,645
2009-12-31 $1,559
2009-09-30 $1,392
2009-06-30 $1,264
2009-03-31 $1,201
2008-12-31 $1,107
2008-09-30 $1,071
2008-06-30 $1,012
2008-03-31 $1,018
2007-12-31 $879
2007-09-30 $860
2007-06-30 $865
2007-03-31 $857
2006-12-31 $744
2006-09-30 $639
2006-06-30 $607
2006-03-31 $603
2005-12-31 $535
2005-09-30 $428
2005-06-30 $432
2005-03-31 $373
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $88.331B $24.689B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Stock Name Country Market Cap PE Ratio
Moderna (MRNA) United States $172.644B 53.33
Bristol Myers Squibb (BMY) United States $138.015B 9.19
Amgen (AMGN) United States $122.679B 13.29
CSL (CSLLY) Australia $99.800B 0.00
BioNTech SE (BNTX) Germany $81.214B 17.52
Regeneron Pharmaceuticals (REGN) United States $69.002B 11.85
Illumina (ILMN) United States $65.846B 74.81
Vertex Pharmaceuticals (VRTX) United States $48.879B 18.99
Biogen (BIIB) United States $44.106B 12.11
BeiGene (BGNE) Cayman Islands $34.247B 0.00
Genmab (GMAB) Denmark $28.775B 70.66
Genmab (GNMSF) Denmark $28.180B 70.44
Seagen (SGEN) United States $27.374B 46.15
Horizon Therapeutics Public (HZNP) Ireland $23.983B 22.73
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
Alnylam Pharmaceuticals (ALNY) United States $22.340B 0.00
Bio-Techne Corp (TECH) United States $19.926B 89.61
Novavax (NVAX) United States $17.451B 0.00
Exact Sciences (EXAS) United States $16.689B 0.00
ARGENX SE-ADR (ARGX) Netherlands $16.564B 0.00
Repligen (RGEN) United States $16.169B 123.22
Incyte (INCY) United States $15.953B 37.82
BioMarin Pharmaceutical (BMRN) United States $13.966B 100.22
Guardant Health (GH) United States $12.866B 0.00
Zai Lab (ZLAB) China $12.841B 0.00
QIAGEN (QGEN) Netherlands $12.243B 20.73
CureVac (CVAC) Germany $11.355B 0.00
Intellia Therapeutics (NTLA) United States $11.315B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $8.862B 22.76
Biohaven Pharmaceutical Holding (BHVN) United States $8.851B 0.00
Ascendis Pharma (ASND) Denmark $8.660B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $8.456B 30.31
Mirati Therapeutics (MRTX) United States $8.270B 0.00
Acceleron Pharma (XLRN) United States $8.050B 0.00
Beam Therapeutics (BEAM) United States $6.627B 0.00
Vir Biotechnology (VIR) United States $6.553B 0.00
Ultragenyx Pharmaceutical (RARE) United States $6.455B 0.00
Sarepta Therapeutics (SRPT) United States $6.410B 0.00
Exelixis (EXEL) United States $6.342B 69.41
Denali Therapeutics (DNLI) United States $6.305B 178.72
Fate Therapeutics (FATE) United States $6.169B 0.00
NeoGenomics (NEO) United States $5.982B 810.83
Halozyme Therapeutics (HALO) United States $5.893B 24.07
Blueprint Medicines (BPMC) United States $5.859B 16.53
Twist Bioscience (TWST) United States $5.623B 0.00
Legend Biotech (LEGN) United States $5.470B 0.00
Certara (CERT) United States $5.338B 0.00
I-Mab (IMAB) China $5.289B 0.00
Adaptive Biotechnologies (ADPT) United States $5.106B 0.00
Alkermes (ALKS) Ireland $4.937B 145.71
AbCellera Biologics (ABCL) $4.894B 0.00
Arvinas (ARVN) United States $4.723B 0.00
Editas Medicine (EDIT) United States $4.150B 0.00
Reata Pharmaceuticals (RETA) United States $3.872B 0.00
Galapagos (GLPG) Belgium $3.722B 0.00
Arena Pharmaceuticals (ARNA) United States $3.515B 0.00
SpringWorks Therapeutics (SWTX) United States $3.480B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $3.470B 0.00
Prothena (PRTA) Ireland $3.295B 0.00
Kymera Therapeutics (KYMR) United States $3.224B 0.00
ALX Oncology Holdings (ALXO) United States $3.149B 0.00
Insmed (INSM) United States $3.146B 0.00
Emergent Biosolutions (EBS) United States $3.074B 7.41
Amicus Therapeutics (FOLD) United States $2.884B 0.00
Apellis Pharmaceuticals (APLS) United States $2.880B 0.00
Cytokinetics (CYTK) United States $2.764B 0.00
Heska (HSKA) United States $2.716B 520.59
Intra-Cellular Therapies (ITCI) United States $2.666B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.535B 0.00
Seer (SEER) $2.521B 0.00
Myriad Genetics (MYGN) United States $2.485B 0.00
Celldex Therapeutics (CLDX) United States $2.477B 0.00
Morphic Holding (MORF) United States $2.437B 0.00
C4 Therapeutics (CCCC) United States $2.395B 0.00
Vericel (VCEL) United States $2.375B 283.00
Arcus Biosciences (RCUS) United States $2.357B 0.00
Sorrento Therapeutics (SRNE) United States $2.337B 0.00
Atea Pharmaceuticals (AVIR) United States $2.295B 0.00
Ligand Pharmaceuticals (LGND) United States $2.202B 32.21
Berkeley Lights (BLI) United States $2.198B 0.00
Protagonist Therapeutics (PTGX) United States $2.143B 0.00
Instil Bio (TIL) United States $2.125B 0.00
Amarin (AMRN) Ireland $2.044B 517.00
Harmony Biosciences Holdings (HRMY) United States $2.030B 34.57
NGM Biopharmaceuticals (NGM) United States $2.024B 0.00
Myovant Sciences (MYOV) United Kingdom $1.981B 0.00
REGENXBIO (RGNX) United States $1.946B 0.00
Alector (ALEC) United States $1.922B 0.00
Revance Therapeutics (RVNC) United States $1.863B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.845B 0.00
Castle Biosciences (CSTL) United States $1.844B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.819B 0.00
PHARMA MAR SA (PHMMF) Spain $1.737B 0.00
MorphoSys AG (MOR) Germany $1.686B 0.00
UniQure (QURE) Netherlands $1.677B 5.70
Dicerna Pharmaceuticals (DRNA) United States $1.643B 0.00
Global Blood Therapeutics (GBT) United States $1.641B 0.00
Codexis (CDXS) United States $1.615B 0.00
Dynavax Technologies (DVAX) United States $1.597B 0.00
Nurix Therapeutics (NRIX) United States $1.586B 0.00
Inovio Pharmaceuticals (INO) United States $1.584B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.563B 0.00
MaxCyte (MXCT) United States $1.549B 0.00
Zymeworks (ZYME) Canada $1.528B 0.00
Kadmon Holdings (KDMN) United States $1.501B 0.00
Ocugen (OCGN) United States $1.501B 0.00
Bionano Genomics (BNGO) United States $1.452B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.448B 0.00
Travere Therapeutics (TVTX) United States $1.434B 0.00
Genetron Holdings (GTH) China $1.420B 0.00
Scholar Rock Holding (SRRK) United States $1.400B 0.00
Zealand Pharma (ZEAL) Denmark $1.398B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.381B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.380B 0.00
PureTech Health (PRTC) United States $1.379B 0.00
Sangamo Therapeutics (SGMO) United States $1.328B 0.00
Inhibrx (INBX) United States $1.322B 0.00
Agenus (AGEN) United States $1.303B 0.00
BioAtla (BCAB) United States $1.257B 0.00
Coherus BioSciences (CHRS) United States $1.230B 0.00
MannKind (MNKD) United States $1.188B 0.00
Bluebird Bio (BLUE) United States $1.187B 0.00
Avid Bioservices (CDMO) United States $1.172B 238.88
Repare Therapeutics (RPTX) Canada $1.151B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.136B 0.00
Precigen (PGEN) United States $1.134B 0.00
RAPT THERAPTICS (RAPT) United States $1.096B 0.00
Northwest Biotherapeutics (NWBO) United States $1.066B 0.00
Fulcrum Therapeutics (FULC) United States $1.057B 0.00
ImmunityBio (IBRX) United States $1.021B 0.00
Merus (MRUS) Netherlands $1.021B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.020B 0.00
Zealand Pharma (ZLDPF) Denmark $0.997B 0.00
Prometheus Biosciences (RXDX) United States $0.981B 0.00
IDEAYA Biosciences (IDYA) United States $0.968B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.924B 0.00
Sutro Biopharma (STRO) United States $0.923B 0.00
Immatics (IMTX) Germany $0.916B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.908B 28.14
Nkarta (NKTX) United States $0.896B 0.00
BeyondSpring (BYSI) United States $0.882B 0.00
Avidity Biosciences (RNA) United States $0.842B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.829B 0.00
Mesoblast (MESO) Australia $0.825B 0.00
Shattuck Labs (STTK) United States $0.822B 0.00
VBI Vaccines (VBIV) United States $0.794B 0.00
Curis (CRIS) United States $0.748B 0.00
Keros Therapeutics (KROS) United States $0.741B 0.00
Cara Therapeutics (CARA) United States $0.733B 91.44
Xenon Pharmaceuticals (XENE) Canada $0.723B 0.00
Precision BioSciences (DTIL) United States $0.721B 0.00
Amryt Pharma (AMYT) United Kingdom $0.698B 0.00
AnaptysBio (ANAB) United States $0.697B 0.00
Adagene (ADAG) China $0.683B 0.00
Pliant Therapeutics (PLRX) United States $0.676B 0.00
Pharming Group (PHAR) Netherlands $0.659B 0.00
Mersana Therapeutics (MRSN) United States $0.646B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.644B 11.74
Sinovac Biotech (SVA) China $0.642B 6.47
Affimed (AFMD) Germany $0.632B 0.00
Cellectis S.A (CLLS) France $0.630B 0.00
MiMedx (MDXG) United States $0.624B 0.00
Brooklyn ImmunoTherapeutics (BTX) United States $0.619B 0.00
Pharming Group (PHGUF) Netherlands $0.612B 24.44
Ambrx Biopharma (AMAM) United States $0.612B 0.00
Spero Therapeutics (SPRO) United States $0.596B 0.00
Bolt Biotherapeutics (BOLT) United States $0.594B 0.00
G1 THERAPEUTICS (GTHX) United States $0.587B 0.00
Anika Therapeutics (ANIK) United States $0.585B 0.00
Gritstone Bio (GRTS) United States $0.573B 0.00
VistaGen Therapeutics (VTGN) United States $0.563B 0.00
MeiraGTx Holdings (MGTX) United States $0.559B 0.00
ALBIREO PHARMA (ALBO) United States $0.556B 0.00
Epizyme (EPZM) United States $0.549B 0.00
Vaccitech (VACC) United Kingdom $0.548B 0.00
DBV Technologies S.A (DBVT) France $0.544B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.542B 0.00
Akoya Biosciences (AKYA) United States $0.534B 0.00
Inventiva S.A (IVA) France $0.520B 0.00
Clovis Oncology (CLVS) United States $0.507B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.503B 0.00
Seres Therapeutics (MCRB) United States $0.501B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.494B 0.00
AC Immune SA (ACIU) Switzerland $0.493B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.476B 0.00
Verastem (VSTM) United States $0.475B 0.00
ChromaDex (CDXC) United States $0.475B 0.00
XBiotech (XBIT) United States $0.468B 0.00
Selecta Biosciences (SELB) United States $0.461B 0.00
Cel-Sci (CVM) United States $0.454B 0.00
Clene (CLNN) United States $0.450B 0.00
Bellus Health (BLU) Canada $0.436B 0.00
Innate Pharma S.A (IPHA) France $0.433B 0.00
BioDelivery Sciences (BDSI) United States $0.428B 13.15
Oncobiologics (OTLK) United States $0.423B 0.00
Compugen (CGEN) Israel $0.421B 0.00
Arbutus Biopharma (ABUS) United States $0.421B 0.00
Geron (GERN) United States $0.420B 0.00
Clearside Biomedical (CLSD) United States $0.406B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.394B 0.00
Codiak BioSciences (CDAK) United States $0.390B 0.00
Starpharma Holdings (SPHRY) Australia $0.390B 0.00
SQZ Biotechnologies (SQZ) United States $0.388B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.378B 0.00
Cue Biopharma (CUE) United States $0.377B 0.00
Cybin (CYBN) Canada $0.375B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.364B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.364B 0.00
KaloBios Pharmaceuticals (HGEN) United States $0.362B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.351B 0.00
ANI Pharmaceuticals (ANIP) United States $0.351B 9.57
Theratechnologies (THTX) Canada $0.349B 0.00
Athenex (ATNX) United States $0.348B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.343B 0.00
Opthea (OPT) Australia $0.339B 0.00
Athersys (ATHX) United States $0.330B 0.00
Neoleukin Therapeutics (NLTX) United States $0.327B 0.00
CytomX Therapeutics (CTMX) United States $0.326B 0.00
Syros Pharmaceuticals (SYRS) United States $0.326B 0.00
Fortress Biotech (FBIO) United States $0.324B 0.00
Prima BioMed (IMMP) Australia $0.321B 0.00
Cogent Biosciences (COGT) United States $0.320B 0.00
Angion Biomedica (ANGN) United States $0.318B 0.00
INmune Bio (INMB) United States $0.315B 0.00
AquaBounty Technologies (AQB) United States $0.297B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.286B 0.00
WAVE Life Sciences (WVE) Singapore $0.279B 0.00
Puma Biotechnology (PBYI) United States $0.277B 0.00
XOMA (XOMA) United States $0.270B 113.86
Checkpoint Therapeutics (CKPT) United States $0.259B 0.00
Cardiff Oncology (CRDF) United States $0.257B 0.00
Beyond Air (XAIR) United States $0.256B 0.00
IBio (IBIO) United States $0.248B 0.00
Frequency Therapeutics (FREQ) United States $0.240B 0.00
Kamada (KMDA) Israel $0.237B 19.70
Paratek Pharmaceuticals (PRTK) United States $0.233B 0.00
Kaleido Biosciences (KLDO) $0.233B 0.00
OVID THERAPEUTC (OVID) United States $0.231B 2.02
Adicet Bio (ACET) United States $0.231B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.220B 0.00
Adverum Biotechnologies (ADVM) United States $0.213B 0.00
NextCure (NXTC) United States $0.204B 0.00
Kala Pharmaceuticals (KALA) United States $0.198B 0.00
Trevena (TRVN) United States $0.197B 0.00
Talis Biomedical (TLIS) United States $0.196B 0.00
Seelos Therapeutics (SEEL) United States $0.191B 0.00
OSMOTICA PHARM (OSMT) United States $0.185B 0.00
SESEN BIO, INC (SESN) United States $0.181B 0.00
TELA Bio (TELA) United States $0.178B 0.00
GENFIT S.A (GNFT) France $0.174B 0.00
ObsEva SA (OBSV) Switzerland $0.173B 0.00
CorMedix Inc (CRMD) United States $0.170B 0.00
Enzo Biochem (ENZ) United States $0.165B 48.57
VolitionRX (VNRX) United States $0.163B 0.00
HOOKIPA Pharma (HOOK) United States $0.162B 0.00
POXEL SA FRANCE (PXXLF) France $0.161B 0.00
Aptinyx (APTX) United States $0.161B 0.00
Erytech Pharma SA (ERYP) France $0.159B 0.00
Synlogic (SYBX) United States $0.158B 0.00
ADMA Biologics Inc (ADMA) United States $0.157B 0.00
Biofrontera AG (BFRA) Germany $0.156B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.154B 0.00
Galena Biopharma (SLS) United States $0.154B 0.00
ATyr Pharma (LIFE) United States $0.152B 0.00
Catalyst Biosciences (CBIO) United States $0.150B 0.00
Dyadic (DYAI) United States $0.150B 0.00
LogicBio Therapeutics (LOGC) United States $0.149B 0.00
Strongbridge Biopharma (SBBP) United States $0.147B 0.00
Vascular Biogenics (VBLT) Israel $0.147B 0.00
VTv Therapeutics (VTVT) United States $0.146B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.144B 0.00
Nicox SA (NICXF) France $0.142B 0.00
Applied Genetic Technologies (AGTC) United States $0.141B 0.00
Liquidia Technologies (LQDA) United States $0.136B 0.00
PHASEBIO PHARMA (PHAS) United States $0.135B 0.00
Novogen (KZIA) Australia $0.132B 0.00
Purple Biotech (PPBT) Israel $0.128B 0.00
Cyclerion Therapeutics (CYCN) United States $0.127B 0.00
Abeona Therapeutics (ABEO) United States $0.124B 0.00
Voyager Therapeutics (VYGR) United States $0.123B 7.07
Evofem Biosciences (EVFM) United States $0.122B 0.00
Orgenesis (ORGS) United States $0.122B 249.00
Eton Pharmaceuticals (ETON) United States $0.121B 0.00
X4 Pharmaceuticals (XFOR) United States $0.120B 0.00
Yumanity Therapeutics (YMTX) United States $0.119B 0.00
Exicure (XCUR) United States $0.118B 0.00
Viridian Therapeutics (VRDN) United States $0.117B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.115B 0.00
Eyenovia (EYEN) United States $0.115B 0.00
Leap Therapeutics (LPTX) United States $0.107B 0.00
Entera Bio (ENTX) Israel $0.105B 0.00
Palatin Technologies (PTN) United States $0.104B 0.00
Cocrystal Pharma (COCP) United States $0.102B 0.00
Cidara Therapeutics (CDTX) United States $0.100B 0.00
Armata Pharmaceuticals (ARMP) United States $0.096B 0.00
Pluristem Therapeutics (PSTI) Israel $0.091B 0.00
Aadi Bioscience (AADI) United States $0.089B 0.00
Celsion (CLSN) United States $0.088B 0.00
Lumos Pharma (LUMO) United States $0.084B 0.00
Adocia (ADOCY) France $0.083B 0.00
Aptevo Therapeutics (APVO) United States $0.082B 0.00
Zosano Pharma (ZSAN) United States $0.080B 0.00
Advaxis (ADXS) United States $0.079B 0.00
ARAVIVE, INC (ARAV) United States $0.079B 0.00
Emmaus Life Sciences (EMMA) United States $0.079B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.078B 0.00
Aytu BioPharma (AYTU) United States $0.078B 0.00
AEterna Zentaris (AEZS) United States $0.077B 0.00
Liminal BioSciences (LMNL) Canada $0.077B 0.00
ABVC BioPharma (ABVC) United States $0.074B 0.00
Edesa Biotech (EDSA) Canada $0.073B 0.00
TRACON Pharmaceuticals (TCON) United States $0.072B 0.00
Evogene (EVGN) Israel $0.071B 0.00
Celyad SA (CYAD) Belgium $0.070B 0.00
Vaccinex (VCNX) United States $0.070B 0.00
Vyant Bio (VYNT) United States $0.070B 0.00
AIkido Pharma (AIKI) United States $0.069B 0.00
DiaMedica Therapeutics (DMAC) United States $0.068B 0.00
Longeveron (LGVN) United States $0.067B 0.00
Organovo Holdings (ONVO) United States $0.065B 0.00
Enveric Biosciences (ENVB) United States $0.064B 0.00
Protalix BioTherapeutics (PLX) Israel $0.061B 0.00
AnPac Bio-Medical Science (ANPC) China $0.055B 0.00
Forte Biosciences (FBRX) United States $0.054B 0.00
Idera Pharmaceuticals (IDRA) United States $0.054B 0.00
Acorda Therapeutics (ACOR) United States $0.052B 1.09
Genetic Technologies (GENE) Australia $0.052B 0.00
Statera Biopharma (STAB) United States $0.050B 0.00
Antibe Therapeutics (ATBPF) Canada $0.050B 0.00
Windtree Therapeutics (WINT) United States $0.049B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.049B 0.00
ARIDIS PHARMACT (ARDS) United States $0.048B 0.00
Vallon Pharmaceuticals (VLON) United States $0.048B 0.00
BioCardia (BCDA) United States $0.048B 0.00
Soligenix (SNGX) United States $0.046B 0.00
Pulmatrix (PULM) United States $0.045B 0.00
Cyclo Therapeutics (CYTH) United States $0.042B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.038B 0.00
Alimera Sciences (ALIM) United States $0.037B 0.00
Invo BioScience (INVO) United States $0.037B 0.00
Happiness Biotech Group (HAPP) China $0.035B 0.00
Palisade Bio (PALI) United States $0.033B 0.00
Timber Pharmaceuticals (TMBR) United States $0.033B 0.00
ZIVO Bioscience (ZIVO) United States $0.033B 0.00
Lexaria Bioscience (LEXX) Canada $0.032B 0.00
Benitec Biopharma (BNTC) United States $0.030B 0.00
Prana Biotechnology (ATHE) Australia $0.028B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
ThermoGenesis Holdings (THMO) United States $0.028B 0.00
GeoVax Labs (GOVX) United States $0.027B 0.00
Titan Pharmaceuticals (TTNP) United States $0.021B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.014B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
UROGEN PHARMA (URGN) United States $0.000B 0.00